7 Key Takeaways | The Changing Landscape of Federal Funding in the Trump Administration
On July 7, 2025, the National Institutes of Health (NIH) Office of Policy for Extramural Research issued NOT-OD-25-128, titled “Guidance on Enforcement of Closeout Requirements During the Appeals Process” (the Notice). The...more
The U.S. government is pushing to redomesticate the manufacturing of pharmaceutical, biotech, gene therapy, and medical device products, both to bolster U.S. manufacturing generally and to address continuing shortages of...more
The National Institutes of Health (NIH) announced on April 21, 2025, a significant change to the terms and conditions governing federal funding (the Notice) applicable to all NIH grants, cooperative agreements and other...more
We are pleased to invite you to the inaugural D.C. Compliance & Government Investigations Seminar, hosted by Bass, Berry & Sims in collaboration with Watermark Strategies. This complimentary seminar will build upon the...more
Our Government Contracts Group examines how companies can prepare for the Trump Administration’s Rate Change Notice despite the uncertainty of the temporary restraining order that put it on hold....more
On February 26, 2025, President Trump issued Executive Order 14222 entitled, “Implementing the President’s ‘Department of Government Efficiency’ Cost Efficiency Initiative” (hereinafter, the “E.O.”), as well as an...more
On January 27, 2025, the new Administration’s Office of Management and Budget (OMB) issued a Memorandum ordering a total freeze on “all federal financial assistance” that could be targeted under his previous executive orders...more